3af69d03df21eddc…
StudyID:
NCT00051909594 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon. |
| completionDate | 2003-06 |
| conditions | ["Alzheimer's Disease"] |
| enrollmentCount | 200 |
| enrollmentType | null |
| nctId | NCT00051909 |
| phase | PHASE2 |
| sponsorId | eli-lilly-and-company |
| startDate | 2002-11 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease |
| url | https://clinicaltrials.gov/study/NCT00051909 |
Canonical JSON
{
"id": "NCT00051909",
"type": "Study",
"data": {
"briefSummary": "Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon.",
"completionDate": "2003-06",
"conditions": [
"Alzheimer's Disease"
],
"enrollmentCount": 200,
"enrollmentType": null,
"nctId": "NCT00051909",
"phase": "PHASE2",
"sponsorId": "eli-lilly-and-company",
"startDate": "2002-11",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease",
"url": "https://clinicaltrials.gov/study/NCT00051909"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:3af69d03df21eddc817d7872c9878000d29635b6d0509e914727ea643947ac7b